WallStreetZenWallStreetZen

NASDAQ: CMPX
Compass Therapeutics Inc Stock Ownership - Who owns Compass Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Compass Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Vered BiskerleibCHIEF EXECUTIVE OFFICER2024-02-0849,198$1.45
$71.34kSell
Thomas J. SchuetzPRESIDENT2024-02-0844,782$1.45
$64.93kSell
Vered BiskerleibChief Executive Officer2024-01-091,753,125$1.93
$3.38MBuy
Thomas J. SchuetzPresident of RD2024-01-09637,500$1.93
$1.23MBuy
Vered BiskerleibChief Operating Officer2023-11-1764,415$1.50
$96.62kSell
Thomas J. SchuetzCHIEF EXECUTIVE OFFICER2023-11-1744,025$1.50
$66.04kSell

1 of 1

CMPX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CMPX insiders and whales buy or sell their stock.

CMPX Shareholders

What type of owners hold Compass Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Advisors LLC16.25%22,362,850$42.94MInstitution
Adage Capital Partners GP LLC8.09%11,130,000$21.37MInstitution
Blackstone Inc5.59%7,691,561$14.77MInstitution
Blackrock Inc4.81%6,613,637$12.70MInstitution
Thomas J. Schuetz4.78%6,570,566$12.62MInsider
Rock Springs Capital Management LP4.01%5,513,788$10.59MInstitution
Janus Henderson Group PLC3.79%5,216,342$10.02MInstitution
Mpm Bioimpact LLC3.64%5,005,086$9.61MInstitution
Vanguard Group Inc3.05%4,192,529$8.05MInstitution
Fmr LLC3.00%4,130,375$7.93MInstitution

1 of 3

CMPX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CMPX67.49%12.24%Net Buying
VNDA52.39%47.61%Net SellingNet Selling
CDXC10.52%89.48%Net BuyingNet Buying
EDIT63.07%36.93%Net SellingNet Selling
SLDB38.43%61.57%Net Buying
View Top Biotech Stocks

Compass Therapeutics Stock Ownership FAQ

Who owns Compass Therapeutics?

Compass Therapeutics (NASDAQ: CMPX) is owned by 67.49% institutional shareholders, 12.24% Compass Therapeutics insiders, and 20.27% retail investors. Thomas J. Schuetz is the largest individual Compass Therapeutics shareholder, owning 6.57M shares representing 4.78% of the company. Thomas J. Schuetz's Compass Therapeutics shares are currently valued at $12.48M.

If you're new to stock investing, here's how to buy Compass Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.